95 related articles for article (PubMed ID: 19182377)
21. Vascular endothelial growth factor is induced by the inflammatory cytokines interleukin-6 and oncostatin m in human adipose tissue in vitro and in murine adipose tissue in vivo.
Rega G; Kaun C; Demyanets S; Pfaffenberger S; Rychli K; Hohensinner PJ; Kastl SP; Speidl WS; Weiss TW; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Zilberfarb V; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1587-95. PubMed ID: 17525365
[TBL] [Abstract][Full Text] [Related]
22. Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells.
Godoy-Tundidor S; Hobisch A; Pfeil K; Bartsch G; Culig Z
Clin Cancer Res; 2002 Jul; 8(7):2356-61. PubMed ID: 12114440
[TBL] [Abstract][Full Text] [Related]
23. Dexamethasone Attenuates Oncostatin M Production via Suppressing of PI3K/Akt/NF-κB Signaling in Neutrophil-like Differentiated HL-60 Cells.
Han NR; Ko SG; Park HJ; Moon PD
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011361
[TBL] [Abstract][Full Text] [Related]
24. Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130.
Nishimoto N; Ogata A; Shima Y; Tani Y; Ogawa H; Nakagawa M; Sugiyama H; Yoshizaki K; Kishimoto T
J Exp Med; 1994 Apr; 179(4):1343-7. PubMed ID: 8145046
[TBL] [Abstract][Full Text] [Related]
25. Inhibition by glucocorticoids of the formation of interleukin-1 alpha, interleukin-1 beta, and interleukin-6: mediation by decreased mRNA stability.
Amano Y; Lee SW; Allison AC
Mol Pharmacol; 1993 Feb; 43(2):176-82. PubMed ID: 8429822
[TBL] [Abstract][Full Text] [Related]
26. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
[TBL] [Abstract][Full Text] [Related]
27. AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies.
Murakami-Mori K; Taga T; Kishimoto T; Nakamura S
J Clin Invest; 1995 Sep; 96(3):1319-27. PubMed ID: 7657807
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
29. Regulation of the type II oncostatin M receptor expression in lung-derived epithelial cells.
Cichy J; Rose-John S; Puré E
FEBS Lett; 1998 Jun; 429(3):412-6. PubMed ID: 9662460
[TBL] [Abstract][Full Text] [Related]
30. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
Liu J; Hadjokas N; Mosley B; Estrov Z; Spence MJ; Vestal RE
Cytokine; 1998 Apr; 10(4):295-302. PubMed ID: 9617575
[TBL] [Abstract][Full Text] [Related]
31. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer.
Kamiya A; Kinoshita T; Ito Y; Matsui T; Morikawa Y; Senba E; Nakashima K; Taga T; Yoshida K; Kishimoto T; Miyajima A
EMBO J; 1999 Apr; 18(8):2127-36. PubMed ID: 10205167
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of glucocorticoid-induced changes of Na(+), K(+)-ATPase in rat lens by a glucocorticoid receptor antagonist RU486.
Xie GL; Yan H; Lu ZF
Exp Eye Res; 2010 Oct; 91(4):544-9. PubMed ID: 20637751
[TBL] [Abstract][Full Text] [Related]
33. The gp130 ligand oncostatin M regulates tissue inhibitor of metalloproteinases-1 through ERK1/2 and p38 in human adult cardiac myocytes and in human adult cardiac fibroblasts: a possible role for the gp130/gp130 ligand system in the modulation of extracellular matrix degradation in the human heart.
Weiss TW; Kvakan H; Kaun C; Zorn G; Speidl WS; Pfaffenberger S; Maurer G; Huber K; Wojta J
J Mol Cell Cardiol; 2005 Sep; 39(3):545-51. PubMed ID: 15890357
[TBL] [Abstract][Full Text] [Related]
34. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
[TBL] [Abstract][Full Text] [Related]
35. Glucocorticoids inhibit oncostatin M-induced phospholipase A2 gene expression in human hepatoma cells.
Haselmann J; Goppelt-Struebe M
Cytokine; 1997 Mar; 9(3):199-205. PubMed ID: 9126708
[TBL] [Abstract][Full Text] [Related]
36. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis.
Hasegawa M; Sato S; Ihn H; Takehara K
Rheumatology (Oxford); 1999 Jul; 38(7):612-7. PubMed ID: 10461473
[TBL] [Abstract][Full Text] [Related]
37. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
Hsu MP; Frausto R; Rose-John S; Campbell IL
Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-6 cytokine family member oncostatin M is a hair-follicle-expressed factor with hair growth inhibitory properties.
Yu M; Kissling S; Freyschmidt-Paul P; Hoffmann R; Shapiro J; McElwee KJ
Exp Dermatol; 2008 Jan; 17(1):12-9. PubMed ID: 17979974
[TBL] [Abstract][Full Text] [Related]
39. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions.
Ruprecht K; Kuhlmann T; Seif F; Hummel V; Kruse N; Brück W; Rieckmann P
J Neuropathol Exp Neurol; 2001 Nov; 60(11):1087-98. PubMed ID: 11706938
[TBL] [Abstract][Full Text] [Related]
40. Oncostatin M (OSM) primes IL-13- and IL-4-induced eotaxin responses in fibroblasts: regulation of the type-II IL-4 receptor chains IL-4Ralpha and IL-13Ralpha1.
Fritz DK; Kerr C; Botelho F; Stampfli M; Richards CD
Exp Cell Res; 2009 Dec; 315(20):3486-99. PubMed ID: 19799897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
